Form 4: CalciMedica Executive Eric W. Roberts Increases Stake in Company

Eric W. Roberts, Chief Business Officer of CalciMedica, recently acquired 5,000 shares of common stock at $4.04 per share, increasing his beneficial ownership.

Summary

• On August 21, 2024, Eric W. Roberts, the Chief Business Officer of CalciMedica, purchased 5,000 shares of the company's common stock at a price of $4.04 per share.
• Following this transaction, Roberts' direct holdings of common stock amount to 111,373 shares.
• Roberts also has indirect ownership through various entities, including Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA (44,894 shares), FMTC Custodian Roth IRA FBO Eric W. Roberts (10,223 shares), IRA Financial Trust Company CFBO Eric W. Roberts (10,661 shares), Valence Investments SPV IV, LLC (356,989 shares), Valence Investments SPV V, LLC (66,228 shares), and Valence Investments SPV VI, LLC (316,109 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An executive purchasing shares suggests confidence, but it's a routine filing.

Positives

• The purchase of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies and their insiders. They provide transparency into the transactions of company executives and large shareholders.

Stakeholder Impact

• The increased stake of a key executive could positively influence investor sentiment.

Key Dates